AST's Timely Topics in Transplantation
webinar series is available free to members 24/7 online Webinars include "DSA: New Concerns and New Therapies," "New Strategies in Hepatitis Management," and "Meeting the Challenges of Resistance." The AST's Business of Transplantation
live webinar series has concluded, but all eight webinars are available in archive format.
Are we on the right track with new drugs and biologics? Have the targets changed? Where can we really impact outcomes with "technology-omics?" The time has come to integrate our strategies, therapies and technology, and critically assess their merits as we face the enormous task of extending transplant survival. Save the date for the 2014 AST Cutting Edge of Transplantation
where expert clinicians, leading diagnosticians, and world class scientists will address this enormous challenge together with an engaged audience.
When: Feb. 13-16, 2014... Read More...
American Society of Transplantation Board Member Provides Expert Testimony to
House Energy & Commerce Committee in Support of Key Immunosuppressive
Drug Coverage Legislation
Dr. Larry Melton of Baylor University Medical Center offers insight to Congress as it examines reforms to improve the Medicare Part B Drug Program
WASHINGTON, DC, June 28, 2013 - The American Society of Transplantation (AST), an international organization of transplant professionals dedicated to advancing the field of transplantation, today announced that AST Board Member Dr. Larry Melton has offered key testimony... Read More...
* CALL TO ACTION - Contact Your House Member *
Last night the U.S. Senate passed the HIV Organ Policy Equity (HOPE) Act by a unanimous vote. As you know, the American Society of Transplantation (AST) and Washington, DC office have advocated strongly for this bill on Capitol Hill. The Society was most instrumental in securing key Majority support for the bill in the U.S. House of Representatives and has been working collectively with all stakeholders to build bipartisan and bicameral support for the bill. AST is also hosting a meeting of all the HOPE Act stakeholders next week in our DC... Read More...
A case for bariatric surgery among obese renal transplant candidates
By Maria Frisch
Approximately 1 in 3 U.S. adults are obese or have a body mass index of 30 or higher. England and Canada aren't far behind at every 1 in 4. This is unfortunate, given the common association between obesity and excess morbidity and mortality. This association is particularly true in renal transplant surgery. Thus, consideration of presurgical bariatric surgery may be warranted in cases where prescribed dietary therapy and physical activity has failed.... Read More...
In addition to welcoming Dr. Dan Salomon as the AST President, the AST is pleased to welcome three new members to its board: Dr. Larry B. Melton, Ph.D.; Dr. Ronald G. Gill, Ph.D.; and Dr. David P. Nelson. Dr. Kenneth A. Newell, Ph.D., was also voted as president elect. The results of the board of director elections were announced during the Town Hall Meeting at ATC in Seattle on May 20. Welcome to our newest board members, and congratulations to Dr. Newell!
Congratulations to the 2013 Pay It Forward Member-Get-A-Member Campaign Winners!
The following three people encouraged their colleagues to join the AST and because of them, the AST community continues to grow.
Christopher Martin, BS (Pharm) - Grand Prize: Apple iPad and complementary membership dues for 2014
Mourad Alsabaugh, MD - 2nd Prize: $500 AST Bucks
Nicolae Leca, MD - 3rd Prize: $250 AST Bucks
Do you have a colleague that would enjoy all of the wonderful benefits of AST membership? Spread the word and encourage them to join! Visit ... Read More...
Blood tests OK for fibrosis diagnosis in hepatitus C
Blood testing can accurately identify clinically significant fibrosis and cirrhosis in people with hepatitis C virus (HCV) infection and may be an alternative to liver biopsy in some patients, a new study found. The analysis of 172 studies comparing various blood tests to biopsy in HCV patients revealed that some of the simplest, cheapest blood tests performed as well as more expensive, complex tests, reported Dr. Roger Chou, and Ngoc Wasson, MPH, from the Evidence-Based Practice Center at Oregon Health and Science... Read More...
The AST and ASTS have released a joint statement regarding the recent media attention to the OPTN lung allocation policy. Read the statement here
AST/Novartis Basic Science Faculty Development Grant
Dr. Jamil Azzi
Research Title: The Novel Role of P13Ky Pathway in Alloimmunity and Tolerance
Dr. Azzi is an instructor in medicine from Brigham and Women’s Hospital. He is particularly interested in achieving allograft tolerance, and developed an early interest in exploring innovative and safer immunosuppressive strategies. His previous research experiences lead him to conclude that finding tolerogenic strategies relies on targeting key players in the survival of memory and regulatory cells. Dr. Azzi’s goal is to improve patient care as an... Read More...